Denali Therapeutics

DNLI Mid Cap

Healthcare · Biotechnology

Aktualisiert: Apr 5, 2026, 17:43 UTC

$20.65

+4.93% heute

52W: $10.57 – $23.77

52W Low: $10.57 Position: 76.4% 52W High: $23.77

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

—

Kurs/Gewinn-Verhältnis

Forward P/E

—

Erwartetes KGV

P/S Ratio

—

Kurs/Umsatz-Verhältnis

EV/EBITDA

—

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$3.3B

Marktkapitalisierung

Umsatzwachstum

—

YoY Umsatzwachstum

Gewinnmarge

—

Nettomarge

ROE

-45.69%

Eigenkapitalrendite

Beta

1.1

Marktsensitivität

Short Interest

9.97%

% der Aktien leerverkauft

Ø Volumen

1,815,160

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

N/A

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

Starker Kauf

14 Analysten

Ø Kursziel

$36.14

+75.03% Upside

Kursziel Spanne

$25.00 – $42.00

Über das Unternehmen

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor program for peripheral inflammatory diseases; BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; TAK-594/DNL593 program for frontotemporal dementia-granulin; DNL126 program for MPS IIIA (Sanfilippo Syndrome A); and DNL310 Tividenofusp alfa, an enzyme replacement therapy program for MPS II (Hunter Syndrome). Its Enzyme TransportVehicle (TV) programs include DNL952 for the treatment of Pompe disease; DNL111 for Parkinson's and Gaucher diseases; and DNL622 for Hurler syndrome (MPS I). The company's OTV programs also comprise DNL628 targeting tau for Alzheimer's dis

Sektor: Healthcare Branche: Biotechnology Land: United States Mitarbeiter: 503 Börse: NMS

Trading-Daten

50-Day MA: $20.52

200-Day MA: $16.91

Volumen: 1,588,953

Ø Volumen: 1,815,160

Short Ratio: 8.99

Kurs/Buchwert: 3.18x

Verschuldung/EK: 4.17x

Free Cash Flow: $-244,188,752

Wo kann ich Denali Therapeutics kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →